Literature DB >> 26266959

Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?

Heidi N Hilton1, J Dinny Graham1, Christine L Clarke1.   

Abstract

Progesterone (P), which signals through the P receptor (PR), is critical in normal development of the breast, but its signaling axis is also a major driver of breast cancer risk. Here we review recent advances in the understanding of P signaling in the normal human breast, with a focus on the importance of the balance between autocrine and paracrine signaling. To date, most data (which derive largely from mouse models or human breast cancer cell line studies) have demonstrated that the vast majority of PR+ cells appear to act as "sensor" cells, which respond to P stimulation by translating these hormonal cues into paracrine signals. However, growing evidence suggests that, dependent on the cellular context, P may also signal in an autocrine manner in a subset of cells in the normal mouse mammary gland and human breast. It has been suggested that it may be dysregulation of this autocrine signaling, resulting in a "switch" from a predominance of paracrine signaling to autocrine signaling in PR+ cells, which is an early event during breast tumorigenesis. This review summarizes current evidence in the literature that demonstrates the mechanisms through which P acts in the normal human breast, as well as highlighting the important questions that remain unanswered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26266959      PMCID: PMC5414684          DOI: 10.1210/me.2015-1152

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  136 in total

Review 1.  Principles for modulation of the nuclear receptor superfamily.

Authors:  Hinrich Gronemeyer; Jan-Ake Gustafsson; Vincent Laudet
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

Review 2.  Nuclear receptors: one big family.

Authors:  Iain J McEwan
Journal:  Methods Mol Biol       Date:  2009

Review 3.  Determinants and dynamics of genome accessibility.

Authors:  Oliver Bell; Vijay K Tiwari; Nicolas H Thomä; Dirk Schübeler
Journal:  Nat Rev Genet       Date:  2011-07-12       Impact factor: 53.242

4.  Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan.

Authors:  J S Lawson; A S Field; S Champion; D Tran; H Ishikura; D Trichopoulos
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

5.  Effects of low dose tamoxifen on normal breast tissue from premenopausal women.

Authors:  G R de Lima; G Facina; J Y Shida; M B C Chein; P Tanaka; R C Dardes; V C Jordan; L H Gebrim
Journal:  Eur J Cancer       Date:  2003-05       Impact factor: 9.162

6.  Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth.

Authors:  Carol A Sartorius; Djuana M E Harvell; Tianjie Shen; Kathryn B Horwitz
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  Steroid hormone receptor status of mouse mammary stem cells.

Authors:  Marie-Liesse Asselin-Labat; Mark Shackleton; John Stingl; François Vaillant; Natasha C Forrest; Connie J Eaves; Jane E Visvader; Geoffrey J Lindeman
Journal:  J Natl Cancer Inst       Date:  2006-07-19       Impact factor: 13.506

Review 8.  Epigenetic control of embryonic stem cell fate.

Authors:  Nicolaj Strøyer Christophersen; Kristian Helin
Journal:  J Exp Med       Date:  2010-10-25       Impact factor: 14.307

9.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Kyle W Jackson; Erin McNicholas; Mari J Kawamura; Wissam M Abdallah; Max S Wicha
Journal:  Breast Cancer Res       Date:  2004-08-16       Impact factor: 6.466

10.  A Progesterone-CXCR4 Axis Controls Mammary Progenitor Cell Fate in the Adult Gland.

Authors:  Yu-Jia Shiah; Pirashaanthy Tharmapalan; Alison E Casey; Purna A Joshi; Trevor D McKee; Hartland W Jackson; Alexander G Beristain; Michelle A Chan-Seng-Yue; Gary D Bader; John P Lydon; Paul D Waterhouse; Paul C Boutros; Rama Khokha
Journal:  Stem Cell Reports       Date:  2015-02-19       Impact factor: 7.765

View more
  10 in total

1.  Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

Authors:  Wenzhen Ge; Tess V Clendenen; Yelena Afanasyeva; Karen L Koenig; Claudia Agnoli; Louise A Brinton; Joanne F Dorgan; A Heather Eliassen; Roni T Falk; Göran Hallmans; Susan E Hankinson; Judith Hoffman-Bolton; Timothy J Key; Vittorio Krogh; Hazel B Nichols; Dale P Sandler; Minouk J Schoemaker; Patrick M Sluss; Malin Sund; Anthony J Swerdlow; Kala Visvanathan; Mengling Liu; Anne Zeleniuch-Jacquotte
Journal:  Int J Cancer       Date:  2018-02-08       Impact factor: 7.396

2.  BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells.

Authors:  H N Hilton; L J Patterson McDonald; N Santucci; F R van der Bent; A Silvestri; J D Graham; C L Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-18       Impact factor: 2.673

3.  Development of N-(4-Phenoxyphenyl)benzenesulfonamide Derivatives as Novel Nonsteroidal Progesterone Receptor Antagonists.

Authors:  Ayumi Yamada; Yuko Kazui; Hiromasa Yoshioka; Aya Tanatani; Shuichi Mori; Hiroyuki Kagechika; Shinya Fujii
Journal:  ACS Med Chem Lett       Date:  2016-09-15       Impact factor: 4.345

4.  Does circulating progesterone mediate the associations of single nucleotide polymorphisms in progesterone receptor (PGR)-related genes with mammographic breast density in premenopausal women?

Authors:  Jingqin Luo; Adetunji T Toriola; Favour A Akinjiyan; Yunan Han
Journal:  Discov Oncol       Date:  2021-11-03

Review 5.  Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.

Authors:  Katherine A Leehy; Tarah M Regan Anderson; Andrea R Daniel; Carol A Lange; Julie H Ostrander
Journal:  J Mol Endocrinol       Date:  2016-02-01       Impact factor: 5.098

Review 6.  Endocrine disruptors of sex hormone activities.

Authors:  L Varticovski; D A Stavreva; A McGowan; R Raziuddin; G L Hager
Journal:  Mol Cell Endocrinol       Date:  2021-07-30       Impact factor: 4.102

7.  Establishment of a normal-derived estrogen receptor-positive cell line comparable to the prevailing human breast cancer subtype.

Authors:  Branden M Hopkinson; Marie C Klitgaard; Ole William Petersen; René Villadsen; Lone Rønnov-Jessen; Jiyoung Kim
Journal:  Oncotarget       Date:  2017-02-07

8.  Genetic dissection of the different roles of hypothalamic kisspeptin neurons in regulating female reproduction.

Authors:  Luhong Wang; Charlotte Vanacker; Laura L Burger; Tammy Barnes; Yatrik M Shah; Martin G Myers; Suzanne M Moenter
Journal:  Elife       Date:  2019-04-04       Impact factor: 8.140

9.  Does circulating progesterone mediate the associations of single nucleotide polymorphisms in progesterone receptor (PGR)-related genes with mammographic breast density in premenopausal women?

Authors:  Jingqin Luo; Adetunji T Toriola; Favour A Akinjiyan; Yunan Han
Journal:  Discov Oncol       Date:  2021-11-03

Review 10.  Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer.

Authors:  Rasmus Siersbæk; Sanjeev Kumar; Jason S Carroll
Journal:  Genes Dev       Date:  2018-09-01       Impact factor: 11.361

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.